scorecardresearch
Add as a preferred source on Google
Thursday, October 23, 2025
TopicSpinal Muscular Atrophy

Topic: Spinal Muscular Atrophy

Roche patent case: Why SC refused to halt Natco’s generic spinal muscular atrophy drug Risdiplam

Roche had approached Delhi High Court, accusing Natco of violating its Indian patent, before going to the Supreme Court with its petition.

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

New hope for rare disease patients: Rs 900-cr govt project to get high-value drugs at lower rates in works

India has 8.4 to 19 crore rare disease patients, according to health ministry estimates. But current beneficiaries in most cases are kids or those who need relatively less expensive drugs.

On Camera

In Bihar, BJP is courting upper castes—a clear shift from its 2020 strategy

With two parties led by Dalit leaders now part of NDA, the BJP is hopeful of winning a large number of reserved constituencies.

Boom to bust: Haunted by Ketan Parekh saga, 117-yr-old Calcutta Stock Exchange’s future lies in limbo

CSE, one of India’s oldest bourses, is edging towards a voluntary exit. It could never recover from market manipulation scam that caused a payment crisis at exchange back in 2001. 

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.